U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 204958

KENGREAL (CANGRELOR)
50MG/VIAL
Marketing Status: Prescription
Active Ingredient: CANGRELOR
Proprietary Name: KENGREAL
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 50MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N204958
Product Number: 001
Approval Date: Jun 22, 2015
Applicant Holder Full Name: CHIESI USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top